AzTrials
AzTrials

Fine Motor Skill DysfunctionNCT03589872

The Fine Motor Dexterity Under Dual Task in Parkinson's Disease

An observational study of Fine Motor Skill Dysfunction and Parkinson Disease, run by Ordu University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study was planned to investigate the contribution of dual task interference on dexterity related ADL disability in patients with Parkinson's disease. We hypothesised that the dual task interference is an indicator of dexterity related ADL difficulties. Read more about this study

Who is it for?
Ages 50 to 90 yearsHealthy volunteers can take part
What is being tested?
Fine motor dexterity test, nine hole peg test
How many people
53 participants
Where
1 siteTurkey (Türkiye)
Study dates
8 May 2018to 15 Jan 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: community sample:community-dwelling patients with Parkinson disease.

Who may be able to join

  • Diagnosis of idiopathic Parkinson's disease according to the criteria of the United Kingdom brain Bank by neurologist
  • Age 50-90 range
  • having sufficient cognitive status according to the Mini Mental Status Evaluation (24 or above from the Mini Mental Test)

Who cannot join

  • Having orthopedic and neurological disorders affecting hand function,
  • Having sensory problems,
  • Having Diabetus mellitus

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sevim ACARÖZ CANDAN

    Ordu, Altinordu, 52100

Other trials in Turkey (Türkiye)

About this study

Official title: The Contribution of the Dual Task Interference on the Dexterity Related Activities of Daily Living in Parkinson's Disease

This study was planned to investigate the contribution of dual task interference on dexterity related ADL disability in patients with Parkinson's disease. We hypothesised that the dual task interference is an indicator of dexterity related ADL difficulties.

Read the detailed description

We planned this study as a cross sectional trial. 53 patients with Parkinson's disease will be evaluated under 2 different task by nine hole peg test. Besides this assessment the cardinal symptoms (bradykinesia, tremor, rigidity) will be evaluated to determine their contribution on the ADL performance.

Being tested
Fine motor dexterity test, nine hole peg test
Keywords
hand function, dual task, Parkinson disease, activities of daily living
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fine motor dexterity test, nine hole peg testDiagnostic test

    The nine hole peg test will be performed under two different task (1)single task, (2)adding a cognitive task

Study groups in NCT03589872
Study groupRoleWhat they receive
Study Grouppatients with parkinson disease
Receives: Diagnostic Test: Fine motor dexterity test, nine hole peg test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nine hole peg test

    The Nine-Hole Peg Test is used to measure finger dexterity in patients with various neurological diagnoses. The patient must pick up the pegs from the holes and replace them back as fast as possible. The Nine Hole Peg Test should be conducted with the dominant arm first, then nondominant hand. The time will be recorded in second to complete the test. The test will be performed under three task;

    1. single task: Only nine-hole peg test
    2. adding a cognitive task: Nine-hole peg test will be performed with a concurrent cognitive task. The cognitive task is a serial 7 subtraction from numbers changed between 290 and 310 during the performing nine-hole peg test. The time will be recorded.

    Measured: 5 minutes

  2. ADL-related dexterity Questionnaire 24 (DextQ-24)

    Dexterity-related ADL difficulties were measured by the ADL-related dexterity Questionnaire 24 (DextQ-24), including 24 question dealing with bimanual and unimanual activities, which is a reliable and valid disease specific questionnaire to evaluate dexterity in patients with PD. Each question is scored between 1 (no problems) and 4 (need aid to perform task) by the patient's experience. Total score ranged from 24 points to 96 points.

    Measured: 10 minutes

Secondary outcomes (3)
  1. Modified Hoehn and Yahr Scale

    Disease progression will be assessed with modified Hoehn and Yahr Scale. The original scale included stages 1 through 5. Since then, stage 0 has been added, and stages 1.5 and 2.5 have been proposed. This modified scale allocates stages from 0 to 5 to indicate the relative level of disability.

    Stage 0: No signs of disease.

    Stage 1: Unilateral symptoms only.

    Stage 1.5: Unilateral and axial involvement.

    Stage 2: Bilateral symptoms. No impairment of balance.

    Stage 2.5: Mild bilateral disease with recovery on pull test.

    Stage 3: Balance impairment. Mild to moderate disease. Physically independent.

    Stage 4: Severe disability, but still able to walk or stand unassisted.

    Stage 5: Needing a wheelchair or bedridden unless assisted.

    Measured: 2 minutes

  2. Unified Parkinson's Disease Rating Scale (UPDRS) - Section of Activities of Daily Living (ADL)

    The UPDRS- ADL section evaluates the impact of Parkinson disease on ADL according to patient's perspective. The ADL section consists of 13 items for gathering information on the patient's own perception of functional impairment due to PD. Each item scores between 0-4. 0 means normal and 4 means severe impairment. The total score change between 0-52. High scores indicate severe impairment.

    Measured: 10 minutes

  3. Unified Parkinson's Disease Rating Scale (UPDRS) - Motor Section

    Motor section of UPDRS determines the impairment due to the Parkinson's disease. Rigidity, bradykinesia and tremor items which are relating with upper extremity function will be assessed. Each item scores between 0-4. 0 means normal and 4 means severe impairment. The total scores of rigidity, bradykinesia, and tremor, respectively range between 0-8, 0-24 and 0-16.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2018
  2. Study start8 May 2018
  3. Primary completion15 Dec 2018
  4. Study completion15 Jan 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
53 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03589872
Sponsor's protocol ID
OrduU3
Status last verified
Jan 2019
First submitted
5 Jul 2018
Last updated
15 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Fine Motor Skill Dysfunction and Parkinson Disease, run by Ordu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nine hole peg test (time frame: 5 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in